Dr. Prerana Bhatia, MD

Dr. Bhatia practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Bhatia's NPI, 1225492382, was assigned on April 5, 2016. Dr. Bhatia graduated from University Of Minnesota Medical School in 2016. Dr. Bhatia's California license number on file is 152738.

Dr. Bhatia's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Bhatia's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Bhatia is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatia practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bhatia's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bhatia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Bhatia has a license on file in California.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, chronic hypertension, circulation problems and coronary artery disease among the conditions Dr. Bhatia treats.

CMS data shows 1,463 Medicare services from Dr. Bhatia across 19 procedure codes in 2024, for 913 Medicare patients. Medicare paid $119,956 for them.

CMS counts 913 Medicare patients who saw Dr. Bhatia in 2024. The largest group is 65 to 74, with 372 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatia's median patient age at 66, with 51% women.

In 2024, Dr. Bhatia wrote 3,008 Medicare Part D claims for 531 patients. 83% of them were for generic drugs. CMS names the drug for 2,772 of them, across 38 drugs with 11 or more claims each, at $561,232 in total drug cost. In 2023, CMS named 1,637 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bhatia for performance year 2024, reported as part of a group. Dr. Bhatia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhatia as offering telehealth.

Dmand AI links 11 papers to Dr. Bhatia, published from 2012 to 2021. 2018 was the busiest year, with 2. The most frequent topics are Defibrillators, Implantable, Device Removal and Echocardiography, Transesophageal. Dr. Bhatia has published most often in JACC Clin Electrophysiol. Dr. Bhatia's most frequent co-authors are Ulrika Birgersdotter-Green, MD, Swapnil Khoche and Travis L. Pollema, DO.

CMS Open Payments shows 21 general payments to Dr. Bhatia from 7 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 51% of the total. Abbott Laboratories paid the most, $1,296.

Dr. Bhatia graduated from University Of Minnesota Medical School in 2016.

Dr. Bhatia is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.